Overcoming limitations of current Antibody-Drug Conjugates (ADCs) by a novel linker technology

被引：1

作者：

Spycher, Philipp Rene ^{[1
]}

Frei, Julia Carina ^{[2
]}

Wehrmueller, Jori Elias ^{[2
]}

Attinger-Toller, Isabella ^{[1
]}

Grabulovski, Dragan ^{[1
]}

Hechler, Torsten ^{[3
]}

Kulke, Michael ^{[3
]}

Pahl, Andreas ^{[3
]}

Behe, Martin ^{[2
]}

Schibli, Roger ^{[2
]}

机构：

[1] ETH Honggerberg, Araris Biotech AG, Zurich, Switzerland

[2] Paul Scherrer Inst, Villigen, Switzerland

[3] Heidelberg Pharma Res GmbH, Ladenburg, Germany

来源：

CANCER RESEARCH | 2019年 / 79卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2019-LB-106

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB-106

引用

页数：2

共 50 条

[21] Current understandings and prospects of antibody-drug conjugates (ADCs) for the treatment of breast cancer: a narrative review
Hao, Chunfang
Liu, Hong
TRANSLATIONAL BREAST CANCER RESEARCH, 2021, 2
[22] Antibody-drug conjugates: recent advances in conjugation and linker chemistries
Tsuchikama, Kyoji
An, Zhiqiang
PROTEIN & CELL, 2018, 9 (01) : 33 - 46
[23] A dual-enzyme cleavable linker for antibody-drug conjugates
Bargh, Jonathan D.
Walsh, Stephen J.
Ashman, Nicola
Isidro-Llobet, Albert
Carroll, Jason S.
Spring, David R.
CHEMICAL COMMUNICATIONS, 2021, 57 (28) : 3457 - 3460
[24] Antibody-drug conjugates: recent advances in conjugation and linker chemistries
Kyoji Tsuchikama
Zhiqiang An
Protein & Cell, 2018, 9 (01) : 33 - 46
[25] A versatile acid-labile linker for antibody-drug conjugates
Finniss, Mathew C.
Chu, Kevin S.
Bowerman, Charles J.
Luft, J. Christopher
Haroon, Zishan A.
DeSimone, Joseph M.
MEDCHEMCOMM, 2014, 5 (09) : 1355 - 1358
[26] Antibody-Drug Conjugates: Element Technology and General Technology
Manabe, Shino
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2017, 137 (05): : 523 - 524
[27] Effect of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Antibody-Drug Conjugates (ADCs)
Mahmood, Iftekhar
ANTIBODIES, 2021, 10 (04)
[28] Near-Infrared Photoimmunotherapy: Photoactivatable Antibody-Drug Conjugates (ADCs)
Kobayashi, Hisataka
Griffiths, Gary L.
Choyke, Peter L.
BIOCONJUGATE CHEMISTRY, 2020, 31 (01) : 28 - 36
[29] Next-Generation Antibody-Drug Conjugates (ADCs) for Cancer Therapy
Junutula, Jagath Reddy
Gerber, Hans-Peter
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (11): : 972 - 973
[30] Antibody-Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review
Lambert, John M.
Morris, Charles Q.
ADVANCES IN THERAPY, 2017, 34 (05) : 1015 - 1035

← 1 2 3 4 5 →